Latest News and Press Releases
Want to stay updated on the latest news?
-
RALEIGH, N.C., Oct. 1, 2013 (GLOBE NEWSWIRE) -- Baxano Surgical, Inc. (Nasdaq:BAXS), a medical device company focused on designing, developing and marketing minimally invasive products to treat...
-
AxiaLIF Plus and VEO Regulatory Approval in Mexico and Colombia IO-Flex Approved in Turkey RALEIGH, N.C., Sept. 26, 2013 (GLOBE NEWSWIRE) -- Baxano Surgical, Inc. (Nasdaq:BAXS), a medical...
-
Third Quarter and Full Year Revenue Guidance Reaffirmed Shareholder Class-Action Lawsuit Dismissed With Prejudice RALEIGH, N.C., Sept. 20, 2013 (GLOBE NEWSWIRE) -- Baxano Surgical, Inc....
-
- Second Quarter Revenues Were $3.9 Million - - Pro Forma Second Quarter Revenues Were $5.7 Million* - - Net Loss Per Share Was $0.26 for the Quarter - - Excluding Special Items, Net Loss Per...
-
RALEIGH, N.C., July 25, 2013 (GLOBE NEWSWIRE) -- Baxano Surgical, Inc. (Nasdaq:BAXS) announced today that it plans to release second quarter 2013 financial and operating results after market close on...
-
RALEIGH, N.C., July 3, 2013 (GLOBE NEWSWIRE) -- Baxano Surgical, Inc. (Nasdaq:BAXS), a medical device company focused on designing, developing and marketing minimally invasive products to treat...
-
RALEIGH, N.C., June 25, 2013 (GLOBE NEWSWIRE) -- Baxano Surgical, Inc. (Nasdaq:BAXS) announced today that it will participate in the JMP Securities Healthcare Conference in July. Ken Reali,...
-
Trading under new ticker symbol "BAXS" to begin June 3, 2013 Completes financing of $17.2M at $2.28/share Two directors and Vice President of Operations appointed from former Baxano, Inc....
-
- First quarter revenues were $3.1 million - - Net loss per share was $0.26 for the quarter - - Excluding special items, net loss per share was $0.21 for the quarter* - - Acquisition of...
-
RALEIGH, N.C., April 26, 2013 (GLOBE NEWSWIRE) -- TranS1 Inc. (Nasdaq:TSON) announced today that it plans to release first quarter 2013 financial and operating results, and provide an update on the...